Who needs laboratories and who needs statins?: comparative and cost-effectiveness analyses of non-laboratory-based, laboratory-based, and staged primary cardiovascular disease screening guidelines
about
Resource Effective Strategies to Prevent and Treat Cardiovascular DiseaseResponse and participation of underserved populations after a three-step invitation strategy for a cardiometabolic health check.An assessment of community health workers' ability to screen for cardiovascular disease risk with a simple, non-invasive risk assessment instrument in Bangladesh, Guatemala, Mexico, and South Africa: an observational studyCardiovascular Disease Screening By Community Health Workers Can Be Cost-Effective In Low-Resource CountriesCost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular DiseaseIncreasing Prescription Length Could Cut Cardiovascular Disease Burden And Produce Savings In South Africa.Validation of a Cardiovascular Disease Policy Microsimulation Model Using Both Survival and Receiver Operating Characteristic Curves.Self-Reported Stroke Risk Stratification: Reasons for Geographic and Racial Differences in Stroke Study.Determinants of participation in a cardiometabolic health check among underserved groups.Screening for cardiovascular disease risk and subsequent management in low and middle income countries: challenges and opportunities.Cardiovascular Risk Assessment in Angolan Adults: A Descriptive Analysis from CardioBengo, a Community-Based Survey
P2860
Q26768304-4B8E6D89-7143-4E97-A7A1-9ECBF9F928C0Q35763606-F22576F7-426D-4FD7-AA5E-FCBA48E368E4Q36697569-890D5B0E-3E1D-45DA-9C5B-A84328CB7499Q36697592-B87DFAC7-019E-4BE4-9239-32307275C302Q36701872-60056CEF-9824-4D98-834C-B12A37072A07Q36753533-4B610FBF-7924-4B3F-A8F0-BE19547DC133Q38793913-32D7A0D0-4218-47E4-95AB-9F9989BD6637Q40193460-430239B3-4913-4D29-9979-718FB19036C6Q42091190-FF16C5D5-0BB0-4750-A3B5-33E86813080AQ49954874-A8C58522-31F9-4E04-A32E-51AD7C4D6F1DQ58228384-433D5E8F-04CF-450A-8E46-F6F4F553EAA5
P2860
Who needs laboratories and who needs statins?: comparative and cost-effectiveness analyses of non-laboratory-based, laboratory-based, and staged primary cardiovascular disease screening guidelines
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Who needs laboratories and who ...... r disease screening guidelines
@en
Who needs laboratories and who ...... disease screening guidelines.
@nl
type
label
Who needs laboratories and who ...... r disease screening guidelines
@en
Who needs laboratories and who ...... disease screening guidelines.
@nl
prefLabel
Who needs laboratories and who ...... r disease screening guidelines
@en
Who needs laboratories and who ...... disease screening guidelines.
@nl
P2093
P2860
P1476
Who needs laboratories and who ...... r disease screening guidelines
@en
P2093
Ankur Pandya
David Cutler
Thomas A Gaziano
P2860
P356
10.1161/CIRCOUTCOMES.113.000397
P577
2014-01-14T00:00:00Z